TrialInvestigational new drugs2011

Thymidylate synthase (TYMS) enhancer region genotype-directed phase II trial of oral capecitabine for 2nd line treatment of advanced pancreatic cancer.

Colin D Weekes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.